News

21 April 2022 – Dexcom and AMSL Diabetes welcome the recent bi-partisan commitment to providing access to continuous glucose monitoring for all people with Type 1 diabetes in Australia. Expanding the subsidy access to all people with Type 1 diabetes in Australia irrespective of their age and concession card status is an important reform that improves …

Continue reading "Government pledges additional Continuous Glucose Monitoring Subsidies for all Australians living with type 1 diabetes"

April 2022 – AMSL Diabetes is excited to announce the launch of Control-IQ™ technology for the t:slim X2™ insulin pump! The t:slim X2 insulin pump (compatible with Dexcom G6 continuous glucose monitoring) is capable of remote feature updates.* Recently, we welcomed the newest software to launch within Australia; Control-IQ. Control-IQ technology is an advanced hybrid …

Continue reading "Control-IQ Technology for the t:slim X2 Insulin Pump Launches in Australia"

Advanced features not available on any other device Government paves the way for improved access to game-changing technology for eligible Australians living with Type 1 diabetes Sydney, 8 February 2022 – AMSL Diabetes has today announced that the Dexcom G6 Continuous Glucose Monitoring (CGM) system will be available through the Australian Government’s CGM Subsidy Initiative …

Continue reading "National Diabetes Services Scheme (NDSS) fully subsidises the most advanced Dexcom Continuous Glucose Monitoring (CGM) technology"

January 2022 We would like to advise that we have been notified that our delivery couriers are experiencing some delays due to the ongoing COVID-19 crisis. We are continuing to process all orders and thank you for your patience. To help keep our phone lines available for urgent enquiries, if you would like an update …

Continue reading "Courier Shipping Delays may occur due to COVID-19"